Incretin-based therapies like semaglutide and tirzepatide have taken the world by storm - splashed across headlines, hailed as game-changers, and now likely being discussed over brunch. But beneath the...
Some pieces of research completely change the way we think about a condition; some also completely change the way we manage a condition.
General practice can feel relentless. On bad days, back-to-back 10-minute appointments, endless admin, and always running behind can leave you feeling inefficient and overwhelmed. Suggesting to a frazzled...
Cancer diagnosis during pregnancy or in the post-partum period is thankfully a rare occurrence, with an estimated incidence of 1 in 1000 pregnancies in England. A key challenge is distinguishing symptoms...
Whilst we are (rightly) excited about the advent of the SGLT2 inhibitors as a drug class that can improve renal and cardiovascular outcomes in people with CKD, it’s important to remember that the SGLT2...
As a profession when we look at improving cancer care and making earlier diagnoses, we tend to focus on either patient factors like lifestyle, occupation or genetics, or on tumour biology. The differences...